(Q36329468)

English

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Palmitoylethanolamide, endocannabinoids and related cannabimimetic compounds in protection against tissue inflammation and pain: potential use in companion animals (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

endocannabinoids

0 references

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Raffaella Barbero

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Vincenzo Di Marzo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Miolo A

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

The Veterinary Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

173

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

21-30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

A proposed autacoid mechanism controlling mastocyte behaviour

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Cannabinoid receptors and the regulation of immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Mast cells: beyond IgE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Control of pain initiation by endogenous cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Are opioids effective in relieving neuropathic pain?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Cannabimimetic fatty acid derivatives in cancer and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Endovanilloid signaling in pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Histamine induced responses are attenuated by a cannabinoid receptor agonist in human skin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Molecular architecture of the vanilloid receptor. Insights for drug design

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

The clinical picture of neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Physiology of pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Update of the NGF saga

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Nerve growth factor: from neurotrophin to neurokine

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Topical capsaicin--a novel and effective treatment for idiopathic intractable pruritus ani: a randomised, placebo controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Endocannabinoid degradation, endotoxic shock and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

CB2 cannabinoid receptor-mediated peripheral antinociception

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Inhibition of pain responses by activation of CB(2) cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

The effects of capsaicin topical therapy in dogs with atopic dermatitis: a randomized, double-blinded, placebo-controlled, cross-over clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

What is the physiological function of mast cells?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Endocannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2Cannabinoid Receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Cannabinoid modulation of peripheral autonomic and sensory neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Increased Expression of Vanilloid Receptor 1 on Myelinated Primary Afferent Neurons Contributes to the Antihyperalgesic Effect of Capsaicin Cream in Diabetic Neuropathic Pain in Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Anandamide and vanilloid TRPV1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Cannabinoid agonists attenuate capsaicin-induced responses in human skin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Differential roles of CB1 and CB2 cannabinoid receptors in mast cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

A neural pathway for itch.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Hyperalgesia due to nerve damage: role of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Itch: scratching more than the surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Pain modulation by release of the endogenous cannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Endocannabinoids and related fatty acid derivatives in pain modulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Topical capsaicin therapy in humans with hemodialysis-related pruritus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Pathobiology of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TVJL.2005.10.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.TVJL.2005.10.003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16324856%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36329468&oldid=1519385314"